Zepbound bests Wegovy for weight loss in new trial
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Source: Medical Xpress
Close
"Thank You for Choosing TeleSlim Clinic!"
"We Only Accept Cash-Pay Patients in Illinois & Texas"
"Please select an option below to proceed."
Close
